Impact of histamine type-2 receptor antagonists on the anticancer efficacy of gefitinib in patients with non-small cell lung cancer

ConclusionThis study demonstrated that concomitant administration of H2RA with gefitinib does not affect the efficacy of gefitinib.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research